Concepedia

MJ Mitten

MM

2

Publications

62

Citations

2

H-Index

1993

Active since

Affiliations

Abbott Fund(Current)

MJ Mitten is an author at Abbott Fund specializing in autoimmune disease, inflammatory arthritis, and rheumatology.

Top concepts

Publications per year

1993–2012

2

Publications

2

Navitoclax (ABT‐263) and bendamustine ± rituximab induce enhanced killing of non‐Hodgkin's lymphoma tumours <i>in vivo</i>

Scott Ackler, MJ Mitten, J Chen et al. · British Journal of Pharmacology · 2012 · 39 citations · Full text

Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo

J. D. Alder, MJ Mitten, K Jarvis et al. · Antimicrobial Agents and Chemotherapy · 1993 · 23 citations

, , +10

Rows per page

1–2 of 2